Difference between revisions of "Part:BBa K1638004:Experience"
Line 5: | Line 5: | ||
===Applications of BBa_K1638004=== | ===Applications of BBa_K1638004=== | ||
+ | =Team Grenoble-Alpes 2019= | ||
+ | ==IMPROVE OF THE BACTERIAL ADENYLATE CYCLASE TWO HYBRID== | ||
+ | ===Purpose=== | ||
+ | The goal here is to prove that a <u>'''membrane''' bacterial two hybrid</u> ('''m'''BATCH) can be generated and can be functional by improving two biobricks from the original BACTH system:<br> | ||
+ | [https://parts.igem.org/Part:BBa_K1638004 BBa_K1638004] : T18 domain of adenylate cyclase from Bordetella pertussis<br> | ||
+ | [https://parts.igem.org/Part:BBa_K1638004 BBa_K1638004] : T25 domain of adenylate cyclase from Bordetella pertussis'''<br> | ||
+ | <br> | ||
+ | In order to do this, 4 biobricks are created:<br> | ||
+ | [https://parts.igem.org/Part:BBa_K3128017 K3128017] : '''OmpX Wild-Type''' (WT) protein fused with '''T18''' subpart of Bordetella Pertussis AC under constitutive promoter<br> | ||
+ | [https://parts.igem.org/Part:BBa_K3128018 K3128018] : '''OmpX WT''' protein fused with '''T25''' subpart of Bordetella Pertussis AC under constitutive promoter<br> | ||
+ | These two biobricks constitute the negative condition of the mBACTH (free sub-parts condition). OmpX proteins are fused to the adenylate cyclase sub-parts at their N-terminal ends. | ||
+ | The fusion protein move freely in the bacterial outer membrane, but they are not forced to get closer by any mean. <br> | ||
+ | The reconstitution of the adenylate cyclase in this condition is only due to random occurrence between both parts. <br> | ||
+ | The signal measured here is considered as background noise.<br> | ||
+ | <br> | ||
+ | [https://parts.igem.org/Part:BBa_K3128026 K3128026] : '''OmpX WT''' protein fused with '''[https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128021 Leucine-zipper]''' (LZ) and '''T18''' sub-part of Bordetella Pertussis AC under constitutive promoter<br> | ||
+ | [https://parts.igem.org/Part:BBa_K3128027 K3128027] : '''OmpX WT''' protein fused with '''[https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128021 Leucine-zipper]''' and '''T25''' sub-part of Bordetella Pertussis AC under constitutive promoter<br> | ||
+ | These two biobricks constitute the '''positive condition''' of the mBACTH (Leucine Zipper condition). | ||
+ | OmpX proteins are fused to the AC subparts at their N-terminal ends, and a leucine-zipper sequence is added between the signal peptide of OmpX and OmpX gene, | ||
+ | in order to force the physical closeness of OmpX proteins. Leucine zippers are peptides which contain a hydrophobic leucine residue at every seventh position. | ||
+ | They are able to dimerize through interactions between their helices | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | =='''Materials and Methods'''== | ||
+ | |||
+ | ===Bacterial Strain=== | ||
+ | <div style="text-align:justify;"> | ||
+ | The assays are made with streptomycin resistant '''BTH101''' <i>E.Coli</i> strain, which are <i>cya-</i> bacteria.<br> | ||
+ | In this strain, the endogenous adenylate cyclase gene has been deleted in order to obtain a bacterium that is <u>unable to produce endogenous '''cAMP'''</u>, | ||
+ | thus avoiding the presence of potential false positives and making the system more sensitive. | ||
+ | </div> | ||
+ | |||
+ | ===Design of the plasmids=== | ||
+ | <div style="text-align:justify;"> | ||
+ | For the mBACTH, as three biobricks have to be inserted in the bacterium to constitute the entire system, genetic constructions have been made in order to co-transform only two compatible plasmids: | ||
+ | |||
+ | <br> | ||
+ | <i>pOT18-Nlc</i> contains '''OmpX gene fused to the T18''' sub-part and the '''NanoLuciferase gene''' under the control of the '''plac promoter'''; it has an ampicillin resistant gene and the pMB1 replication origin.<br> | ||
+ | <i>pOT18-Nlc</i> contains [https://parts.igem.org/Part:BBa_K3128001 NanoLuciferase reporter for BACTH assay] and [https://parts.igem.org/Part:BBa_K3128017 OmpX WT protein fused with T18 subpart of Bordetella Pertussis AC under constitutive promoter].<br> | ||
+ | <i>pOT25</i> contains '''OmpX gene fused to the T25 subpart'''. It has a kanamycin resistant gene and the p15A replication origin.<br> | ||
+ | <i>pOT25</i> contains [https://parts.igem.org/Part:BBa_K3128018 OmpX WT protein fused with T25 subpart of Bordetella Pertussis AC under constitutive promoter].<br> | ||
+ | '''Those constructs will be the negative condition that show the background noise of the initial mBACTH system.'''<br> | ||
+ | |||
+ | <br> | ||
+ | <i>pOT18-Nlc-ZIP</i> is similar to <i>pOT18-Nlc</i> with the addition of a '''leucine-zipper''' sequence between the '''OmpX signal peptide''' and the '''OmpX gene'''.<br> | ||
+ | <i>pOT18-Nlc-ZIP</i> contains [https://parts.igem.org/Part:BBa_K3128001 NanoLuciferase reporter for BACTH assay] and [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128026 OmpX WT protein fused with LZ and T18 subpart of Bordetella Pertussis AC under constitutive promoter].<br> | ||
+ | <i>pOT25-ZIP</i> is similar to <i>pOT25</i> with the addition of a '''leucine-zipper''' sequence between the '''OmpX signal peptide''' and the '''OmpX gene'''. <br> | ||
+ | <i>pOT25-ZIP</i> contains [https://parts.igem.org/wiki/index.php?title=Part:BBa_K3128027 OmpX WT protein fused with LZ and T25 subpart of Bordetella Pertussis AC under constitutive promoter].<br> | ||
+ | '''Those constructs will be the positive condition that show how the signal increases if both sub-parts are brought together with the mBACTH.'''<br> | ||
+ | |||
+ | https://2019.igem.org/wiki/images/thumb/f/f9/T--Grenoble-Alpes--mBACTH_plamides.png/800px-T--Grenoble-Alpes--mBACTH_plamides.png | ||
+ | |||
+ | ===Transformation=== | ||
+ | For the assay with the membrane BACTH, BTH101 are co-transformed either with <u><i>pOT18-Nlc</i> and <i>pOT25</i> plasmids</u> : '''negative condition''',<br> | ||
+ | or <u><i>pOT18-Nlc-ZIP</i> and <i>pOT25-ZIP</i> plasmids</u> : '''positive condition'''.<br> | ||
+ | |||
+ | ===The assay=== | ||
+ | <div style="text-align:justify;"> | ||
+ | To make sure that the '''OmpX-T18''' and '''OmpX-T25''' are expressed in the external membrane, '''OmpX''' proteins have been muted to be able to integrate an unnatural amino acid in one of their extracellular loops by implementing the amber stop codon TAG. | ||
+ | A specific tRNA can then add this azide-functionalized amino acid in the protein, which is able to fix a DIBO group - these modified proteins are called '''COMPs'''. <br> | ||
+ | COMPs are fused with T18 or T25 subparts and have to be expressed at the external membrane of the bacteria. To ensure this, | ||
+ | microscopy observations have been done with a DIBO group coupled with a fluorescent molecule : FITC. <br> | ||
+ | '''Results of the COMP, COMP-T18 and COMP-T25 proteins marked show a great protein expression on the external membrane. (Link vers les résultats).'''<br> | ||
+ | <br> | ||
+ | The bioluminescence intensity produced by the NanoLuciferase enzyme is analyzed.<br> | ||
+ | Several conditions are tested with 100µL, 25µL, 5µL and 1µL of bacteria at OD600nm = 0.6 : respectively 48E+06 CFU, 12E+06 CFU, 24E+05 CFU and 48E+04 CFU .<br> | ||
+ | In addition, times of induction are tested <u>from 0 to 360 minutes with 30 minutes increments</u>.<br> | ||
+ | Cultures of the different recombinant bacteria are incubated overnight at 18°C under shaking in order to induce an optimal COMPs proteins production [http://2015.igem.org/Team:TU_Eindhoven cf Team Eindhoven 2015].<br> | ||
+ | The low temperature allows a native protein folding and membrane insertion to avoids as much as possible the formation of inclusion bodies.<br> | ||
+ | <br> | ||
+ | Then cultures are diluted at OD600nm = 0,4 and let to grow to OD 600nm = 0.6 before induction.<br> | ||
+ | The induction is performed by addition of '''0,5 mM IPTG''' and '''2mM of ATP''' for different periods of time. Bacteria are incubated at '''37°C''' under shaking (180 rpm) to allow an optimal '''NanoLuciferase production'''.<br> | ||
+ | <br> | ||
+ | After induction, 1, 5, 25 or 100µL of bacteria are distributed in a 96 wells black NUNC plate (ThermoFisher) the Nano-Glo® Luciferase Assay assay from Promega® is performed [https://france.promega.com/products/reporter-assays-and-transfection/reporter-assays/nano_glo-luciferase-assay-system/?catNum=N1110 (More informations)] : <br> | ||
+ | “Prepare the desired amount of reconstituted Nano-Glo® Luciferase Assay Reagent by combining one volume of Nano-Glo® Luciferase Assay Substrate with 50 volumes of Nano-Glo® Luciferase Assay Buffer.For example, if the experiment requires 10 mL of reagent, add 200μl of substrate to 10 mL of buffer.”<br> | ||
+ | The bioluminescence is then observed with a luminometer by measuring Relative Luminescence Units (RLU).<br> | ||
+ | <br> | ||
+ | Several measures are made in the same well in order to reduce the incertitudes induced by the luminometer.<br> | ||
+ | In order to test the '''reproducibility''' of our measures the means of '''3 differents experiments''' with '''3 measurements per well''' are measured with the calculation of standard deviation for each. <br> | ||
+ | <br> | ||
+ | '''Several controls are performed''':<br> | ||
+ | '''∅ IPTG, ∅ ATP''' : To check the promoter leakage without any induction.<br> | ||
+ | '''∅ IPTG, 2 mM ATP''' :To check if the addition of extracellular ATP helps the production of cAMP and to check if addition of ATP modifies the promoter leakage.<br> | ||
+ | '''0,5 mM IPTG, ∅ ATP''' : To check if adding extracellular ATP is needed for protein expression.<br> | ||
+ | '''0,5 mM IPTG, 2 ATP''' : Is the normal condition, it correspond to the measure at 360min.<br> | ||
+ | <br> | ||
+ | ==Results== | ||
+ | <br> | ||
+ | The '''mBACTH''' following results are obtained with '''5µL''' of bacteria at OD600nm = 0.6 : '''24E+05 CFU'''.<br> | ||
+ | <i>With 1µL (48E+04 CFU), the bioluminescence intensity was too low and the measurement were not discriminant enough.<br> | ||
+ | Above 25µL of bacteria (12E+06 CFU), the signal was quickly saturated when the induction time increased and the luminometer could not give workable measures.<br> | ||
+ | 5µL (24E+05 CFU) is a good compromise, it’s enough to have a discriminant signal and sensitive enough to work as a small drop in our NeuroDrop system.<br> | ||
+ | iGEM Grenoble-Alpes device NeuroDrop is designed for the use of small volumes like drops. | ||
+ | Proving that 5µL of bacteria are enough to detect a significant difference in bioluminescence intensity between negative and positive condition is an encouraging result. | ||
+ | Other reagents (see the full system) will be added to the drop of bacteria and its volume should not exceed 20µL for the engineers machine to work. 5µL of bacteria seem to be appropriate.</i><br> | ||
+ | <br> | ||
+ | https://2019.igem.org/wiki/images/7/77/T--Grenoble-Alpes--mBACTH_Table_1.png <br> | ||
+ | <i> Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either <br> | ||
+ | BBa_K3128018 and BBa_K3128017 : '''free sub-parts : negative condition''',<br> | ||
+ | or BBa_K3128026 and BBa_K3128027 : '''Leucine Zipper : positive condition'''.<br> | ||
+ | Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted from the measurements.</i><br> | ||
+ | <br> | ||
+ | With '''1,48E+06 RLU''' of bioluminesce produced in the '''0,5 mM IPTG''' condition compared to '''9,02E+05''' in the condition '''without IPTG and without ATP''', it seems that <u>IPTG increase slightly the transcription</u>.<br> | ||
+ | Additionally, with '''2,55E+0,6 RLU''' of bioluminescence produced in the''' without ATP and 2mM ATP''' condition compared to '''9,02E+05''' in the '''without ATP and IPTG condition''', it seems that <u>ATP have a '''significant*''' effect on transcription</u>. <br> | ||
+ | This was expected because of the lack of ATP in the periplasm of the bacteria. Thereby, <u>adding a great amount of ATP in the medium able to diffuse in the periplasm help the cAMP production by the periplasmic adenylate cyclase</u>.<br> | ||
+ | Obviously, those observations don’t prove anything but give clues on the way the system operates. <br> | ||
+ | <i>* A T test was done for the values of time above 90 min and led to a p-value below 0.01.</i><br> | ||
+ | <br> | ||
+ | https://2019.igem.org/wiki/images/thumb/7/72/T--Grenoble-Alpes--mBACTH_Graph_1.png/800px-T--Grenoble-Alpes--mBACTH_Graph_1.png <br> | ||
+ | <i>Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either <br> | ||
+ | BBa_K3128018 and BBa_K3128017 : '''free sub-parts : negative condition''', <br> | ||
+ | or BBa_K3128026 and BBa_K3128027 : '''Leucine Zipper : positive condition'''. <br> | ||
+ | Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted from the measurements.<br></i> | ||
+ | <i>* A T test was done for the values of time above 210 min and led to a p-value below 0.05.</i><br> | ||
+ | <br> | ||
+ | <u>From 0 to 120 minutes</u> of induction time, the <u>bioluminescence produced by the two strains is similar</u>. <br> | ||
+ | At '''120 minutes''', the <u>two curves start to split</u> and give rise to a <u>significant difference</u> between the free sub-parts : negative condition and the Leucine Zipper: positive condition from around '''210 minutes'''.<br> | ||
+ | <br> | ||
+ | The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the '''amplification signal''' thanks to the signalling cascade and the strong reporter gene.<br> | ||
+ | |||
+ | <u>From 0 to 120 minutes</u> of induction time, the <u>bioluminescence produced by the two strains is similar</u>. <br> | ||
+ | At '''120 minutes''', the <u>two curves start to split</u> and give rise to a <u>significant difference</u> between the free sub-parts (negative condition) and the Leucine Zipper (positive condition) from around '''210 minutes'''.<br> | ||
+ | <br> | ||
+ | The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the '''amplification signal''' thanks to the signalling cascade and the strong reporter gene.<br> | ||
+ | |||
+ | <br> | ||
+ | ==Conclusion== | ||
+ | '''There is a <u>significant difference between the negative and the positive condition of the mBACTH assay</u>''', <br> | ||
+ | '''suggesting that a Bacterial Adenylate Cyclase Two-Hybrid can be successfully performed in the periplasm of bacteria which property is required for the sensing and detection of extracellular molecules.'''<br> | ||
+ | |||
+ | ==User Reviews== | ||
+ | <!-- DON'T DELETE --><partinfo>BBa_K3128017 StartReviews</partinfo> | ||
+ | <!-- Template for a user review | ||
+ | {|width='80%' style='border:1px solid gray' | ||
+ | |- | ||
+ | |width='10%'| | ||
+ | <partinfo>BBa_K3128017 AddReview number</partinfo> | ||
+ | <I>Username</I> | ||
+ | |width='60%' valign='top'| | ||
+ | Enter the review inofrmation here. | ||
+ | |}; | ||
+ | <!-- End of the user review template --> | ||
+ | <!-- DON'T DELETE --><partinfo>BBa_K3128017 EndReviews</partinfo> | ||
+ | |||
===User Reviews=== | ===User Reviews=== |
Revision as of 18:14, 10 October 2019
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K1638004
Team Grenoble-Alpes 2019
IMPROVE OF THE BACTERIAL ADENYLATE CYCLASE TWO HYBRID
Purpose
The goal here is to prove that a membrane bacterial two hybrid (mBATCH) can be generated and can be functional by improving two biobricks from the original BACTH system:
BBa_K1638004 : T18 domain of adenylate cyclase from Bordetella pertussis
BBa_K1638004 : T25 domain of adenylate cyclase from Bordetella pertussis
In order to do this, 4 biobricks are created:
K3128017 : OmpX Wild-Type (WT) protein fused with T18 subpart of Bordetella Pertussis AC under constitutive promoter
K3128018 : OmpX WT protein fused with T25 subpart of Bordetella Pertussis AC under constitutive promoter
These two biobricks constitute the negative condition of the mBACTH (free sub-parts condition). OmpX proteins are fused to the adenylate cyclase sub-parts at their N-terminal ends.
The fusion protein move freely in the bacterial outer membrane, but they are not forced to get closer by any mean.
The reconstitution of the adenylate cyclase in this condition is only due to random occurrence between both parts.
The signal measured here is considered as background noise.
K3128026 : OmpX WT protein fused with Leucine-zipper (LZ) and T18 sub-part of Bordetella Pertussis AC under constitutive promoter
K3128027 : OmpX WT protein fused with Leucine-zipper and T25 sub-part of Bordetella Pertussis AC under constitutive promoter
These two biobricks constitute the positive condition of the mBACTH (Leucine Zipper condition).
OmpX proteins are fused to the AC subparts at their N-terminal ends, and a leucine-zipper sequence is added between the signal peptide of OmpX and OmpX gene,
in order to force the physical closeness of OmpX proteins. Leucine zippers are peptides which contain a hydrophobic leucine residue at every seventh position.
They are able to dimerize through interactions between their helices
Materials and Methods
Bacterial Strain
The assays are made with streptomycin resistant BTH101 E.Coli strain, which are cya- bacteria.
In this strain, the endogenous adenylate cyclase gene has been deleted in order to obtain a bacterium that is unable to produce endogenous cAMP,
thus avoiding the presence of potential false positives and making the system more sensitive.
Design of the plasmids
For the mBACTH, as three biobricks have to be inserted in the bacterium to constitute the entire system, genetic constructions have been made in order to co-transform only two compatible plasmids:
pOT18-Nlc contains OmpX gene fused to the T18 sub-part and the NanoLuciferase gene under the control of the plac promoter; it has an ampicillin resistant gene and the pMB1 replication origin.
pOT18-Nlc contains NanoLuciferase reporter for BACTH assay and OmpX WT protein fused with T18 subpart of Bordetella Pertussis AC under constitutive promoter.
pOT25 contains OmpX gene fused to the T25 subpart. It has a kanamycin resistant gene and the p15A replication origin.
pOT25 contains OmpX WT protein fused with T25 subpart of Bordetella Pertussis AC under constitutive promoter.
Those constructs will be the negative condition that show the background noise of the initial mBACTH system.
pOT18-Nlc-ZIP is similar to pOT18-Nlc with the addition of a leucine-zipper sequence between the OmpX signal peptide and the OmpX gene.
pOT18-Nlc-ZIP contains NanoLuciferase reporter for BACTH assay and OmpX WT protein fused with LZ and T18 subpart of Bordetella Pertussis AC under constitutive promoter.
pOT25-ZIP is similar to pOT25 with the addition of a leucine-zipper sequence between the OmpX signal peptide and the OmpX gene.
pOT25-ZIP contains OmpX WT protein fused with LZ and T25 subpart of Bordetella Pertussis AC under constitutive promoter.
Those constructs will be the positive condition that show how the signal increases if both sub-parts are brought together with the mBACTH.
Transformation
For the assay with the membrane BACTH, BTH101 are co-transformed either with pOT18-Nlc and pOT25 plasmids : negative condition,
or pOT18-Nlc-ZIP and pOT25-ZIP plasmids : positive condition.
The assay
To make sure that the OmpX-T18 and OmpX-T25 are expressed in the external membrane, OmpX proteins have been muted to be able to integrate an unnatural amino acid in one of their extracellular loops by implementing the amber stop codon TAG.
A specific tRNA can then add this azide-functionalized amino acid in the protein, which is able to fix a DIBO group - these modified proteins are called COMPs.
COMPs are fused with T18 or T25 subparts and have to be expressed at the external membrane of the bacteria. To ensure this,
microscopy observations have been done with a DIBO group coupled with a fluorescent molecule : FITC.
Results of the COMP, COMP-T18 and COMP-T25 proteins marked show a great protein expression on the external membrane. (Link vers les résultats).
The bioluminescence intensity produced by the NanoLuciferase enzyme is analyzed.
Several conditions are tested with 100µL, 25µL, 5µL and 1µL of bacteria at OD600nm = 0.6 : respectively 48E+06 CFU, 12E+06 CFU, 24E+05 CFU and 48E+04 CFU .
In addition, times of induction are tested from 0 to 360 minutes with 30 minutes increments.
Cultures of the different recombinant bacteria are incubated overnight at 18°C under shaking in order to induce an optimal COMPs proteins production [http://2015.igem.org/Team:TU_Eindhoven cf Team Eindhoven 2015].
The low temperature allows a native protein folding and membrane insertion to avoids as much as possible the formation of inclusion bodies.
Then cultures are diluted at OD600nm = 0,4 and let to grow to OD 600nm = 0.6 before induction.
The induction is performed by addition of 0,5 mM IPTG and 2mM of ATP for different periods of time. Bacteria are incubated at 37°C under shaking (180 rpm) to allow an optimal NanoLuciferase production.
After induction, 1, 5, 25 or 100µL of bacteria are distributed in a 96 wells black NUNC plate (ThermoFisher) the Nano-Glo® Luciferase Assay assay from Promega® is performed (More informations) :
“Prepare the desired amount of reconstituted Nano-Glo® Luciferase Assay Reagent by combining one volume of Nano-Glo® Luciferase Assay Substrate with 50 volumes of Nano-Glo® Luciferase Assay Buffer.For example, if the experiment requires 10 mL of reagent, add 200μl of substrate to 10 mL of buffer.”
The bioluminescence is then observed with a luminometer by measuring Relative Luminescence Units (RLU).
Several measures are made in the same well in order to reduce the incertitudes induced by the luminometer.
In order to test the reproducibility of our measures the means of 3 differents experiments with 3 measurements per well are measured with the calculation of standard deviation for each.
Several controls are performed:
∅ IPTG, ∅ ATP : To check the promoter leakage without any induction.
∅ IPTG, 2 mM ATP :To check if the addition of extracellular ATP helps the production of cAMP and to check if addition of ATP modifies the promoter leakage.
0,5 mM IPTG, ∅ ATP : To check if adding extracellular ATP is needed for protein expression.
0,5 mM IPTG, 2 ATP : Is the normal condition, it correspond to the measure at 360min.
Results
The mBACTH following results are obtained with 5µL of bacteria at OD600nm = 0.6 : 24E+05 CFU.
With 1µL (48E+04 CFU), the bioluminescence intensity was too low and the measurement were not discriminant enough.
Above 25µL of bacteria (12E+06 CFU), the signal was quickly saturated when the induction time increased and the luminometer could not give workable measures.
5µL (24E+05 CFU) is a good compromise, it’s enough to have a discriminant signal and sensitive enough to work as a small drop in our NeuroDrop system.
iGEM Grenoble-Alpes device NeuroDrop is designed for the use of small volumes like drops.
Proving that 5µL of bacteria are enough to detect a significant difference in bioluminescence intensity between negative and positive condition is an encouraging result.
Other reagents (see the full system) will be added to the drop of bacteria and its volume should not exceed 20µL for the engineers machine to work. 5µL of bacteria seem to be appropriate.
Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either
BBa_K3128018 and BBa_K3128017 : free sub-parts : negative condition,
or BBa_K3128026 and BBa_K3128027 : Leucine Zipper : positive condition.
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted from the measurements.
With 1,48E+06 RLU of bioluminesce produced in the 0,5 mM IPTG condition compared to 9,02E+05 in the condition without IPTG and without ATP, it seems that IPTG increase slightly the transcription.
Additionally, with 2,55E+0,6 RLU of bioluminescence produced in the without ATP and 2mM ATP condition compared to 9,02E+05 in the without ATP and IPTG condition, it seems that ATP have a significant* effect on transcription.
This was expected because of the lack of ATP in the periplasm of the bacteria. Thereby, adding a great amount of ATP in the medium able to diffuse in the periplasm help the cAMP production by the periplasmic adenylate cyclase.
Obviously, those observations don’t prove anything but give clues on the way the system operates.
* A T test was done for the values of time above 90 min and led to a p-value below 0.01.
Means of measurements obtained through 3 differents experiments with 3 measurements per well for each condition of the mBACTH generated with either
BBa_K3128018 and BBa_K3128017 : free sub-parts : negative condition,
or BBa_K3128026 and BBa_K3128027 : Leucine Zipper : positive condition.
Blank was done with 24E+05 CFU of untransformed BTH101 (RLU = 300) and subtracted from the measurements.
* A T test was done for the values of time above 210 min and led to a p-value below 0.05.
From 0 to 120 minutes of induction time, the bioluminescence produced by the two strains is similar.
At 120 minutes, the two curves start to split and give rise to a significant difference between the free sub-parts : negative condition and the Leucine Zipper: positive condition from around 210 minutes.
The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the amplification signal thanks to the signalling cascade and the strong reporter gene.
From 0 to 120 minutes of induction time, the bioluminescence produced by the two strains is similar.
At 120 minutes, the two curves start to split and give rise to a significant difference between the free sub-parts (negative condition) and the Leucine Zipper (positive condition) from around 210 minutes.
The discrepancy keeps increasing upon induction time, thus highlighting the efficiency of the amplification signal thanks to the signalling cascade and the strong reporter gene.
Conclusion
There is a significant difference between the negative and the positive condition of the mBACTH assay,
suggesting that a Bacterial Adenylate Cyclase Two-Hybrid can be successfully performed in the periplasm of bacteria which property is required for the sensing and detection of extracellular molecules.
User Reviews
UNIQ6394f40ef4ed1624-partinfo-00000000-QINU UNIQ6394f40ef4ed1624-partinfo-00000001-QINU
User Reviews
UNIQ6394f40ef4ed1624-partinfo-00000002-QINU
UNIQ6394f40ef4ed1624-partinfo-00000003-QINU